Substituted Tricyclic Compounds, inhibitors of Fibroblast Growth Factor receptor (FGFR)； Pharmaceutical composition that comprises； a method for treating cancer, myeloproliferative disorder, disorder of Skeletal Disorder, hypophosphataemia, among others.

• 收藏
• 分享

专利权人:

INCYTE CORPORATION

发明人:

YAO, WENQING,HE, CHUNHONG,WU. LIANGXING,ZHANG, COLIN,SUN, YAPING,LU, LIANG,QIAN, DING-QUAN,XU, MEIZHONG,ZHUO, JINCONG

申请号：

CL2014003355

公开号：

CL2014003355A1

申请日:

2014.12.10

申请国别(地区):

CL

年份:

2015

代理人:

摘要：

The present invention relates to tricyclic compounds of formula (I), and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.<；p>；LA SOLICITUD SE REFIERE A COMPUESTOS DERIVADOS DE TETRAHIDROPIRROLO[3&rsquo；,2&rsquo；:5,6]PIRIDO[4,3-D]PIRIMIDINONA, INHIBIDORES FGFR, A UNA COMPOSICIÓ；N FARMACÉ；UTICA QUE LOS COMPRENDE Y A SU USO EN EL TRATAMIENTO DEL CÁ；NCER O UN TRASTORNO CONDROCITICO O ESQUELÉ；TICO.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/